201. Breast MRI and invasive lobular carcinoma: An update

2014 ◽  
Vol 40 (11) ◽  
pp. S85-S86
Author(s):  
M. Morais ◽  
A. Pinho ◽  
A. Magalhães ◽  
S. Costa ◽  
F. Osório ◽  
...  
2016 ◽  
Vol 22 (2) ◽  
pp. 143-150 ◽  
Author(s):  
Muhammad Asad Parvaiz ◽  
Peiming Yang ◽  
Eisha Razia ◽  
Margaret Mascarenhas ◽  
Caroline Deacon ◽  
...  

2012 ◽  
Vol 53 (4) ◽  
pp. 367-375 ◽  
Author(s):  
Aude Stivalet ◽  
Alain Luciani ◽  
Frederic Pigneur ◽  
Thu Ha Dao ◽  
Pauline Beaussart ◽  
...  

2015 ◽  
Vol 18 (1) ◽  
pp. 63 ◽  
Author(s):  
Na Young Jung ◽  
Sung Hoon Kim ◽  
Sung Hun Kim ◽  
Ye Young Seo ◽  
Jin Kyoung Oh ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
David Chiang ◽  
Michael Lee ◽  
Pauline Germaine ◽  
Lydia Liao

We present an interesting case of focal amyloidosis of the left breast which was intermixed with ductal carcinoma in situ (DCIS). On subsequent staging bilateral breast magnetic resonance imaging (MRI), the patient was found to have an additional suspicious enhancing mass with spiculated borders within the left breast. This mass was biopsy proven to represent pleomorphic invasive lobular carcinoma. A pulmonary nodule within the lingula was also noted on the staging bilateral breast MRI and was biopsy proven to represent extranodal Castleman’s disease. Therefore, it is believed that our patient had secondary amyloidosis due to Castleman’s disease.


2006 ◽  
Vol 30 (2) ◽  
pp. 146-149
Author(s):  
N. Fabre Demard ◽  
P. Boulet ◽  
X. Prat ◽  
L. Charra ◽  
A. Lesnik ◽  
...  

2011 ◽  
Vol 77 (10) ◽  
pp. 1368-1371 ◽  
Author(s):  
Briana Lau ◽  
Lina M. Romero

The role of breast magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer remains controversial. The objective of this study is to determine the impact of preoperative breast MRI on patients with biopsy-proven invasive lobular carcinoma (ILC) initially deemed eligible for breast conserving therapy. We analyzed a prospective cohort study of patients with biopsy-proven ILC that consented to undergo preoperative diagnostic MRI at our institution. Data analysis of 20 patients accrued from January 2010 through January 2011 was performed. Outcome measures included discovery of occult lesions, need for additional biopsies, change in surgical management, and need for surgical reexcision. MRI found an additional cancer in 40 per cent of patients and increased extent of disease in one patient. MRI led to eight biopsies, for a pathologically confirmed true positive rate of 82 per cent [95% confidence interval (CI) 62-101%] and only two unnecessary biopsies. Preoperative MRI beneficially altered surgical management in 42 per cent of patients (95% CI 19-65%) without leading to unnecessary surgery, and only one patient required reexcision for positive margins (5.8%, CI -5.8-17.4%). In conclusion, preoperative MRI in patients with ILC can detect additional disease that was missed by conventional workup, allowing for better preoperative planning and more appropriate oncologic resection.


Sign in / Sign up

Export Citation Format

Share Document